Emcure Pharmaceuticals Ltd (EMCURE) — Financial Flexibility Index
Emcure Pharmaceuticals Ltd (EMCURE) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of Rs3.85 Billion (operating CF Rs2.56 Billion minus capex Rs1.29 Billion) represents 0% of total liabilities (Rs45.09 Billion). Check cash flow reinvestment rate of Emcure Pharmaceuticals Ltd to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Emcure Pharmaceuticals Ltd Financial Flexibility Index (2022–2026)
Historical Financial Flexibility Index trend for Emcure Pharmaceuticals Ltd across 5 annual periods. For the full cash flow conversion analysis, see Emcure Pharmaceuticals Ltd operating cash flow efficiency.
Annual Financial Flexibility Index for Emcure Pharmaceuticals Ltd (2022–2026)
Year-by-year free cash flow to debt coverage for Emcure Pharmaceuticals Ltd. Explore Emcure Pharmaceuticals Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.26x | Rs12.11 Billion | Rs8.51 Billion | Rs46.36 Billion | ▼ -25.5% |
| 2025 | 0.35x | Rs12.59 Billion | Rs8.52 Billion | Rs35.91 Billion | ▲ +16.9% |
| 2024 | 0.30x | Rs14.04 Billion | Rs10.97 Billion | Rs46.84 Billion | ▲ +4.9% |
| 2023 | 0.29x | Rs11.50 Billion | Rs7.47 Billion | Rs40.23 Billion | ▼ -3.1% |
| 2022 | 0.30x | Rs11.65 Billion | Rs7.68 Billion | Rs39.49 Billion | — |